Helen M. Burt
- Biomaterials top 0.1%
- Molecular Biology top 5%
- Biomedical Engineering top 1%
- Organic Chemistry top 1%
- Pharmaceutical Science top 0.1%
- Co-authors
- John K. JacksonKevin LetchfordRichard LigginsWilliam L. HunterXichen ZhangKatherine J. HaxtonStephen K. DordunooMu Chiao
- Topics
- Nanoparticle-Based Drug Delivery (34 papers)Cancer Treatment and Pharmacology (23 papers)Advanced Drug Delivery Systems (15 papers)
- Partner nations
- CanadaUnited StatesDenmark
In The Last Decade
Helen M. Burt
168 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Biomaterials 3.5k
- Molecular Biology 1.7k
- Biomedical Engineering 1.7k
- Organic Chemistry 1.4k
- Pharmaceutical Science 1.3k
Countries citing papers authored by Helen M. Burt
This map shows the geographic impact of Helen M. Burt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen M. Burt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen M. Burt more than expected).
Fields of papers citing papers by Helen M. Burt
This network shows the impact of papers produced by Helen M. Burt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen M. Burt. The network helps show where Helen M. Burt may publish in the future.
Co-authorship network of co-authors of Helen M. Burt
This figure shows the co-authorship network connecting the top 25 collaborators of Helen M. Burt. A scholar is included among the top collaborators of Helen M. Burt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen M. Burt. Helen M. Burt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Catalyzing Clusters of Research Excellence: An Institutional Case Study. | 2 |
| 2 | 6 | |
| 3 | 14 | |
| 4 | 51 | |
| 5 | 27 | |
| 6 | 21 | |
| 7 | 36 | |
| 8 | 34 | |
| 9 | 73 | |
| 10 | 15 | |
| 11 | Time-dependent inhibition of CYP3A4 by mibefradil in recombinant CYP3A4 and human liver microsomes and impact on in vivo predictions. | 1 |
| 12 | 35 | |
| 13 | 54 | |
| 14 | 70 | |
| 15 | 11 | |
| 16 | 86 | |
| 17 | 28 | |
| 18 | 47 | |
| 19 | 51 | |
| 20 | 17 |
About Helen M. Burt
Helen M. Burt is a scholar working on Biomaterials, Pharmaceutical Science and Oncology, having authored 168 papers that have together received 8.0k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (34 papers), Cancer Treatment and Pharmacology (23 papers) and Advanced Drug Delivery Systems (15 papers). The work is most often cited by research in Biomaterials (3.5k citations), Pharmaceutical Science (1.3k citations) and Molecular Medicine (516 citations). Helen M. Burt has collaborated with scholars based in Canada, United States and Denmark. Frequent co-authors include John K. Jackson, Kevin Letchford, Richard Liggins, William L. Hunter, Xichen Zhang, Katherine J. Haxton, Stephen K. Dordunoo, Mu Chiao, Martin Gleave and Jason Zastre. Their work appears in journals such as The Journal of Immunology, Biomaterials and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.